Through our partnership with Diaceutics, we are pleased to offer the Personalized Medicine (PM) Buzz.
Compiled and curated from top global resources, the PM Buzz is a monthly snapshot of:
- The latest news
- Industry developments
- Headline stories in the world of personalized (precision) medicine.
What’s happening in the PM industry…
- NICE flip-flops to back Bristol-Myers’ Opdivo in head and neck cancer despite data ‘uncertainties’ read on…
- Ignyta NSCLC durability data set stage for Pfizer fight read on…
- AstraZeneca’s Lynparza ups the ante at the PARP table with FDA’s speedy breast cancer review read on…
- Australia: Genetic testing for patients with high risk of breast, ovarian cancer now free read on…
- Foundation Medicine receives approval from the state of New York for its FoundationACT liquid biopsy assay read on…
Subscribe to receive future PM Buzz Reports. |
Learn More About Diaceutics
Diaceutics is a global group of experts from the laboratory, diagnostic and pharmaceutical industries with the goal of helping pharmaceutical companies integrate diagnostic testing into their treatment pathways. Diaceutics is empowered through a real-time flow of testing data from their worldwide laboratory network which they use to help their pharma clients understand and leverage the diagnostic landscape. Learn more about Diaceutics.